Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 5:07 PM
Ignite Modification Date:
2025-12-24 @ 5:07 PM
NCT ID:
NCT03972150
Pre Assignment Details:
All subjects were screened for eligibility prior to participation in the trial. Subjects attended a specialist site which ensured that they (the subjects) strictly met all inclusion and none of the exclusion criteria. Subjects were not to be allocated to a treatment group if any of the entry criteria were violated.
Recruitment Details:
This was a phase I, open label, uncontrolled, non-randomized, two parts, dose-escalation design trial assessing the Maximum Tolerated Dose (MTD) and/or Recommended Phase 2 Dose (RP2D), safety, tolerability, Pharmacokinetics (PK) and Pharmacodynamics (Pd) of BI 836880 monotherapy, and combination therapy of BI 836880 and BI 754091 in Japanese patients with different types of advanced cancer.
Study:
NCT03972150
Study Brief:
Results Section:
NCT03972150